CD27 (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "CD27" in Czech language version.

refsWebsite

Global rank Czech rank

9doi.org

2^nd place

4^th place

7worldcat.org

5^th place

3^rd place

5nih.gov

4^th place

8^th place

2elsevier.com

610^th place

203^rd place

2ashpublications.org

low place

2nature.com

234^th place

72^nd place

1pnas.org

1,293^rd place

205^th place

1web.archive.org

1^st place

1biomedcentral.com

2,747^th place

459^th place

1jimmunol.org

low place

5,054^th place

ashpublications.org

BUCHAN, Sarah L.; ROGEL, Anne; AL-SHAMKHANI, Aymen. The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy. Blood. 2018-01-04, roč. 131, čís. 1, s. 39–48. Dostupné online [cit. 2022-05-31]. ISSN 0006-4971. doi:10.1182/blood-2017-07-741025. (anglicky)
ANSELL, Stephen M.; FLINN, Ian; TAYLOR, Matthew H. Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies. Blood Advances. 2020-05-12, roč. 4, čís. 9, s. 1917–1926. Dostupné online [cit. 2022-05-31]. ISSN 2473-9529. doi:10.1182/bloodadvances.2019001079. PMID 32380537. (anglicky)

biomedcentral.com

jeccr.biomedcentral.com

FLIESWASSER, Tal; VAN DEN EYNDE, Astrid; VAN AUDENAERDE, Jonas. The CD70-CD27 axis in oncology: the new kids on the block. Journal of Experimental & Clinical Cancer Research. 2022-12, roč. 41, čís. 1, s. 12. Dostupné online [cit. 2022-05-31]. ISSN 1756-9966. doi:10.1186/s13046-021-02215-y. PMID 34991665. (anglicky)

doi.org

STARZER, Angelika M.; BERGHOFF, Anna S. New emerging targets in cancer immunotherapy: CD27 (TNFRSF7). ESMO Open. 2019, roč. 4, s. e000629. Dostupné online [cit. 2022-05-31]. doi:10.1136/esmoopen-2019-000629. PMID 32152062. (anglicky)
BUCHAN, Sarah L.; ROGEL, Anne; AL-SHAMKHANI, Aymen. The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy. Blood. 2018-01-04, roč. 131, čís. 1, s. 39–48. Dostupné online [cit. 2022-05-31]. ISSN 0006-4971. doi:10.1182/blood-2017-07-741025. (anglicky)
PRASAD, K. V. S.; AO, Zhaohui; YOON, Yoosik. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proceedings of the National Academy of Sciences. 1997-06-10, roč. 94, čís. 12, s. 6346–6351. Dostupné online [cit. 2022-05-31]. ISSN 0027-8424. doi:10.1073/pnas.94.12.6346. PMID 9177220. (anglicky) Archivováno 31. 5. 2022 na Wayback Machine.
HAN, Bobby Kwanghoon; OLSEN, Nancy J.; BOTTARO, Andrea. The CD27–CD70 pathway and pathogenesis of autoimmune disease. Seminars in Arthritis and Rheumatism. 2016-02, roč. 45, čís. 4, s. 496–501. Dostupné online [cit. 2022-05-31]. doi:10.1016/j.semarthrit.2015.08.001. (anglicky)
NOLTE, Martijn A; ARENS, Ramon; VAN OS, Ronald. Immune activation modulates hematopoiesis through interactions between CD27 and CD70. Nature Immunology. 2005-04, roč. 6, čís. 4, s. 412–418. Dostupné online [cit. 2022-05-31]. ISSN 1529-2908. doi:10.1038/ni1174. (anglicky)
FLIESWASSER, Tal; VAN DEN EYNDE, Astrid; VAN AUDENAERDE, Jonas. The CD70-CD27 axis in oncology: the new kids on the block. Journal of Experimental & Clinical Cancer Research. 2022-12, roč. 41, čís. 1, s. 12. Dostupné online [cit. 2022-05-31]. ISSN 1756-9966. doi:10.1186/s13046-021-02215-y. PMID 34991665. (anglicky)
RIBOT, Julie C; DEBARROS, Ana; PANG, Dick John. CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17–producing γδ T cell subsets. Nature Immunology. 2009-04, roč. 10, čís. 4, s. 427–436. Dostupné online [cit. 2022-05-31]. ISSN 1529-2908. doi:10.1038/ni.1717. PMID 19270712. (anglicky)
VOSSEN, Mireille T. M.; MATMATI, Mourad; HERTOGHS, Kirsten M. L. CD27 Defines Phenotypically and Functionally Different Human NK Cell Subsets. The Journal of Immunology. 2008-03-15, roč. 180, čís. 6, s. 3739–3745. Dostupné online [cit. 2022-05-31]. ISSN 0022-1767. doi:10.4049/jimmunol.180.6.3739. (anglicky)
ANSELL, Stephen M.; FLINN, Ian; TAYLOR, Matthew H. Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies. Blood Advances. 2020-05-12, roč. 4, čís. 9, s. 1917–1926. Dostupné online [cit. 2022-05-31]. ISSN 2473-9529. doi:10.1182/bloodadvances.2019001079. PMID 32380537. (anglicky)

elsevier.com

linkinghub.elsevier.com

STARZER, Angelika M.; BERGHOFF, Anna S. New emerging targets in cancer immunotherapy: CD27 (TNFRSF7). ESMO Open. 2019, roč. 4, s. e000629. Dostupné online [cit. 2022-05-31]. doi:10.1136/esmoopen-2019-000629. PMID 32152062. (anglicky)
HAN, Bobby Kwanghoon; OLSEN, Nancy J.; BOTTARO, Andrea. The CD27–CD70 pathway and pathogenesis of autoimmune disease. Seminars in Arthritis and Rheumatism. 2016-02, roč. 45, čís. 4, s. 496–501. Dostupné online [cit. 2022-05-31]. doi:10.1016/j.semarthrit.2015.08.001. (anglicky)

jimmunol.org

VOSSEN, Mireille T. M.; MATMATI, Mourad; HERTOGHS, Kirsten M. L. CD27 Defines Phenotypically and Functionally Different Human NK Cell Subsets. The Journal of Immunology. 2008-03-15, roč. 180, čís. 6, s. 3739–3745. Dostupné online [cit. 2022-05-31]. ISSN 0022-1767. doi:10.4049/jimmunol.180.6.3739. (anglicky)

nature.com

NOLTE, Martijn A; ARENS, Ramon; VAN OS, Ronald. Immune activation modulates hematopoiesis through interactions between CD27 and CD70. Nature Immunology. 2005-04, roč. 6, čís. 4, s. 412–418. Dostupné online [cit. 2022-05-31]. ISSN 1529-2908. doi:10.1038/ni1174. (anglicky)
RIBOT, Julie C; DEBARROS, Ana; PANG, Dick John. CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17–producing γδ T cell subsets. Nature Immunology. 2009-04, roč. 10, čís. 4, s. 427–436. Dostupné online [cit. 2022-05-31]. ISSN 1529-2908. doi:10.1038/ni.1717. PMID 19270712. (anglicky)

nih.gov

ncbi.nlm.nih.gov

STARZER, Angelika M.; BERGHOFF, Anna S. New emerging targets in cancer immunotherapy: CD27 (TNFRSF7). ESMO Open. 2019, roč. 4, s. e000629. Dostupné online [cit. 2022-05-31]. doi:10.1136/esmoopen-2019-000629. PMID 32152062. (anglicky)
PRASAD, K. V. S.; AO, Zhaohui; YOON, Yoosik. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proceedings of the National Academy of Sciences. 1997-06-10, roč. 94, čís. 12, s. 6346–6351. Dostupné online [cit. 2022-05-31]. ISSN 0027-8424. doi:10.1073/pnas.94.12.6346. PMID 9177220. (anglicky) Archivováno 31. 5. 2022 na Wayback Machine.
FLIESWASSER, Tal; VAN DEN EYNDE, Astrid; VAN AUDENAERDE, Jonas. The CD70-CD27 axis in oncology: the new kids on the block. Journal of Experimental & Clinical Cancer Research. 2022-12, roč. 41, čís. 1, s. 12. Dostupné online [cit. 2022-05-31]. ISSN 1756-9966. doi:10.1186/s13046-021-02215-y. PMID 34991665. (anglicky)
RIBOT, Julie C; DEBARROS, Ana; PANG, Dick John. CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17–producing γδ T cell subsets. Nature Immunology. 2009-04, roč. 10, čís. 4, s. 427–436. Dostupné online [cit. 2022-05-31]. ISSN 1529-2908. doi:10.1038/ni.1717. PMID 19270712. (anglicky)
ANSELL, Stephen M.; FLINN, Ian; TAYLOR, Matthew H. Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies. Blood Advances. 2020-05-12, roč. 4, čís. 9, s. 1917–1926. Dostupné online [cit. 2022-05-31]. ISSN 2473-9529. doi:10.1182/bloodadvances.2019001079. PMID 32380537. (anglicky)

pnas.org

PRASAD, K. V. S.; AO, Zhaohui; YOON, Yoosik. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proceedings of the National Academy of Sciences. 1997-06-10, roč. 94, čís. 12, s. 6346–6351. Dostupné online [cit. 2022-05-31]. ISSN 0027-8424. doi:10.1073/pnas.94.12.6346. PMID 9177220. (anglicky) Archivováno 31. 5. 2022 na Wayback Machine.

web.archive.org

PRASAD, K. V. S.; AO, Zhaohui; YOON, Yoosik. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proceedings of the National Academy of Sciences. 1997-06-10, roč. 94, čís. 12, s. 6346–6351. Dostupné online [cit. 2022-05-31]. ISSN 0027-8424. doi:10.1073/pnas.94.12.6346. PMID 9177220. (anglicky) Archivováno 31. 5. 2022 na Wayback Machine.

worldcat.org

BUCHAN, Sarah L.; ROGEL, Anne; AL-SHAMKHANI, Aymen. The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy. Blood. 2018-01-04, roč. 131, čís. 1, s. 39–48. Dostupné online [cit. 2022-05-31]. ISSN 0006-4971. doi:10.1182/blood-2017-07-741025. (anglicky)
PRASAD, K. V. S.; AO, Zhaohui; YOON, Yoosik. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proceedings of the National Academy of Sciences. 1997-06-10, roč. 94, čís. 12, s. 6346–6351. Dostupné online [cit. 2022-05-31]. ISSN 0027-8424. doi:10.1073/pnas.94.12.6346. PMID 9177220. (anglicky) Archivováno 31. 5. 2022 na Wayback Machine.
NOLTE, Martijn A; ARENS, Ramon; VAN OS, Ronald. Immune activation modulates hematopoiesis through interactions between CD27 and CD70. Nature Immunology. 2005-04, roč. 6, čís. 4, s. 412–418. Dostupné online [cit. 2022-05-31]. ISSN 1529-2908. doi:10.1038/ni1174. (anglicky)
FLIESWASSER, Tal; VAN DEN EYNDE, Astrid; VAN AUDENAERDE, Jonas. The CD70-CD27 axis in oncology: the new kids on the block. Journal of Experimental & Clinical Cancer Research. 2022-12, roč. 41, čís. 1, s. 12. Dostupné online [cit. 2022-05-31]. ISSN 1756-9966. doi:10.1186/s13046-021-02215-y. PMID 34991665. (anglicky)
RIBOT, Julie C; DEBARROS, Ana; PANG, Dick John. CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17–producing γδ T cell subsets. Nature Immunology. 2009-04, roč. 10, čís. 4, s. 427–436. Dostupné online [cit. 2022-05-31]. ISSN 1529-2908. doi:10.1038/ni.1717. PMID 19270712. (anglicky)
VOSSEN, Mireille T. M.; MATMATI, Mourad; HERTOGHS, Kirsten M. L. CD27 Defines Phenotypically and Functionally Different Human NK Cell Subsets. The Journal of Immunology. 2008-03-15, roč. 180, čís. 6, s. 3739–3745. Dostupné online [cit. 2022-05-31]. ISSN 0022-1767. doi:10.4049/jimmunol.180.6.3739. (anglicky)
ANSELL, Stephen M.; FLINN, Ian; TAYLOR, Matthew H. Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies. Blood Advances. 2020-05-12, roč. 4, čís. 9, s. 1917–1926. Dostupné online [cit. 2022-05-31]. ISSN 2473-9529. doi:10.1182/bloodadvances.2019001079. PMID 32380537. (anglicky)